Opko Health Inc. OPK
Analyst Ratings
- Consensus
- Hold — 0 Buy · 3 Hold · 0 Sell (3 analysts)
- Avg. Price Target
- $1.60 (+2.6% upside)
Key Stats
- Today's Range
- $1.55 – $1.58
- 50-Day Range
- $1.18 – $1.75
- 52-Week Range
- $0.98 – $1.75
- Volume
- 1.40 million shs
- Average Volume
- 2.72 million shs
- Market Cap
- $1.17 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 7.65%
- Days to Cover
- 15.45
About Opko Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Related Stocks
Compare head-to-head: OPK vs LLY·OPK vs JNJ·OPK vs ABBV·OPK vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.